Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women

Obstetrics and Gynecology

Volumn 97, Issue 2, 2001, Pages 161-168

  Chen, Katherine T ^a,b   Sell, Randall L ^a,b   Tuomala, Ruth E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Joseph L Mailman School of Public Health of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PERINATAL INFECTION; PRIORITY JOURNAL; VAGINAL DELIVERY; VIRUS LOAD; VIRUS TRANSMISSION;

CESAREAN SECTION; COST-BENEFIT ANALYSIS; DECISION TREES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SURGICAL PROCEDURES, ELECTIVE; UNITED STATES; ZIDOVUDINE;

EID: 0035122329     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)01107-8     Document Type: Article

References (39)

1. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group
2. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
3. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial
4. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial
5. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
6. Caesarean section and risk of vertical transmission of HIV-1 infection
7. Mother-to-child transmission of human immunodeficiency virus type 1: Influence of parity and mode of delivery
8. Prevention of vertical HIV transmission: Additive protective effect of elective Cesarean section and zidovudine prophylaxis
9. Perinatal HIV-1 transmission: Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort
10. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - A meta-analysis of 15 prospective cohort studies. The International Perinatal HIV Group
11. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial
12. Maternal and neonatal morbidity and mortality in cesarean section
13. Maternal mortality and morbidity in cesarean section
14. Maternal consequences of caesarean section. A retrospective study of intra-operative and postoperative maternal complications of caesarean section during a 10-year period
15. Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment
16. The incidence of complications after caesarean section in 156 HIV-positive women
17. Prevention of mother-to-child transmission of HIV-1 infection: Alternative strategies and their cost-effectiveness
18. Projection of AIDS and HIV incidence among children born infected with HIV
19. A randomised trial of mode of delivery in women infected with the human immunodeficiency virus
20. Perinatal mortality and maternal morbidity in spontaneous and forceps vaginal delivery
21. Postoperative cesarean section morbidity: A prospective study
22. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties
23. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: Results of Pediatric AIDS Clinical Trials Group protocol 185
24. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
25. Lifetime cost of care for children with human immunodeficiency virus infection
26. Universal HIV screening of pregnant women in England: Cost effectiveness analysis
27. Pediatric human immunodeficiency virus infection. Recent evidence on the utilization and costs of health services
28. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine
29. Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency viurs in unregistered parturients: A cost-effectiveness analysis
30. Preventing perinatal transmission of HIV - Costs and effectiveness of a recommended intervention
31. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States
32. Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women
33. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study
34. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood
35. Update: Universal precautions for prevention of transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health-care settings
36. Public service guidelines for the management of health care workers exposed to HIV and recommendations for post-exposure prophylaxis